Category: Pharmaceuticals

Pharmaceuticals • 28.04.25

Merck Acquires US Cancer Specialist Springworks in $3 Billion Deal

Merck acquires Springworks Therapeutics for $3 billion, boosting its oncology pipeline with innovative cancer treatments. A game-changer for rare disease therapies.

StockTimes Content Team

1
Media • 14.11.25

The $1 Billion Broadcast: A Legal, Political, and Media Firestorm Ignites

StockTimes Content Team
Politics • 06.03.25

Germany’s Bold Spending Plans: A Strategic Message to Global Powers

StockTimes Content Team
Cryptocurrency • 19.10.25

XRP and SOL Forge Their Own Path: A Bullish Options Divergence Emerges

StockTimes Content Team
Geopolitics • 26.04.25

Ukraine War Update: Potential Peace Plan Concessions and Diplomatic Shifts

StockTimes Content Team
Technology • 05.03.25

The Impact of US Export Controls on ASML and the Global Chip Industry

StockTimes Content Team
Investing • 18.10.25

The Buffett Doctrine: Why Productive Assets Trump "Sterile" Gold

StockTimes Content Team

Categories

Tags